- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06180915
The Effect of Peer Education Based on Assertiveness Skills on Dating Violence Attitudes and Internalized Misogyny
This study will be conducted to evaluate the effect of assertiveness training given through peer education on dating violence attitudes and internalized misogyny. In this study ; Nursing takes a role in helping individuals obtain and protect their rights as part of its advocacy role, investigates the obstacles to assertive behavior and solutions to develop assertive behavior as part of its researcher role, takes a role in educating individuals on assertiveness as part of its educational role, and finds solutions to individuals' problems as part of its consultancy role. It will play an active role in students' roles such as being able to produce, providing problem-solving skills with appropriate coping methods.
This study aims to empower women by providing a positive change in the perception of dating violence attitudes and internalized misogyny through peer education based on assertiveness training. It is thought that with this study, the assertiveness behavior of female students studying at the university will be improved and a positive change will be achieved in the perception of dating violence attitudes and internalized misogyny.
The population of the study is female students studying at the university, and female students studying in the midwifery department were selected due to the high density of female students. Female students of Tarsus University Midwifery Department were selected as the intervention group and female students of Mersin University were selected as the control group.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: BUSRA GOK
- Phone Number: +905380930633
- Email: busragok@tarsus.edu.tr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participant must be over 18 years of age
- The participant is a woman
- The participant's ability to read, speak and write Turkish
- The participant must have had a dating relationship at least once in his or her life or is currently in a dating relationship.
Exclusion Criteria:
- Students who agree to participate in the research but do not attend any sessions of the training, who do not want to fill out the required surveys at any stage of the research, or who want to withdraw from the research at any stage of the research will be excluded from the sample.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental Group
Participants will be informed that they must answer the surveys and forms completely and appropriately, as well as attend all training sessions and fulfill their session duties.
At the end of the 3-week training program (interim measurement) and 4 weeks later (post-test), the Rathus Assertiveness Inventory, Internalized Misogyny Scale and Flirting Violence Attitude Scale will be converted into an online survey via Google Forms®, the link will be sent to the participants and they will be asked to fill it out.
|
The peer trainer will be subjected to assertiveness training based on dating violence and internalized misogyny by the researcher for 2 hours a day for 5 days.
The peer educator will create a Whatsapp group with the experimental group participants and a name for the group will be found by mutual decision.
The peer educator will schedule a time and date with the group.
Each session will last approximately 60 minutes and the total training duration will be planned to be 3 weeks.
One week and one month after the training is completed, the participants will fill out the scales again.
|
No Intervention: Control Group
The control group will not be subjected to any training.
The Control Group will fill out the Introductory Information Form, Rathus Assertiveness Inventory, Internalized Misogyny Scale, Flirting Violence Scale and Cyber Flirting Violence Scale simultaneously with the experimental group at the beginning of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The impact of Peer Education Based on Assertiveness Skills
Time Frame: Within 2 month
|
The behavioral change attitude that occurs 1 week after the training will be measured according to the Passivity, Assertiveness and Aggression Scale, Internalized Misogyny Scale and Dating Violence Attitude Scale scores. Passivity, Assertiveness and Aggression Scale: Total score varies between 10 and 40. While low scores from the scale indicate high levels of passivity, assertiveness and aggression, high scores indicate low levels of passivity, assertiveness and aggression. Internalized Misogyny Scale: The total score that can be obtained from the scale varies between 17-119, and as the score increases, internalized misogyny also increases. Dating Violence Attitude Scale: The highest score that can be obtained from each item is 5 and the lowest score is 1. The average score of the scale approaching 5 indicates that individuals' attitudes towards dating violence are negative and they do not support dating violence behaviour. |
Within 2 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- bsrgk33
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dating Violence
-
Centers for Disease Control and PreventionBaltimore City Health Department; NORC at the University of Chicago; Ogilvy Public... and other collaboratorsCompletedTeen Dating Violence | Healthy Dating Relationship BehaviorsUnited States
-
Boston UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Western University, CanadaRecruitingAdolescent Behavior | Dating ViolenceCanada
-
Rhode Island HospitalRecruitingAdolescent Dating ViolenceUnited States
-
Istanbul University - Cerrahpasa (IUC)Not yet recruitingIntimate Partner Violence | Dating Violence | Nursing Students | Bystander Effect
-
Kent State UniversityCompletedDating ViolenceUnited States
-
University of DeustoMedikosta IMQ Análisis ClínicosCompleted
-
University of Nebraska LincolnUniversity of Houston; University of Colorado, Colorado SpringsCompleted
-
Boston UniversityU.S. Department of JusticeCompletedSexual Aggression | Offensive Aggression | Dating Violence Perpetration and VictimizationUnited States
-
Rhode Island HospitalUnknownHIV Infections | Dating ViolenceUnited States
Clinical Trials on The peer trainer will be subjected to assertiveness training based on dating violence and internalized misogyny by the researcher for 2 hours a day for 5 days.
-
Memorial Sloan Kettering Cancer CenterCompletedNon-Hodgkin's Lymphoma | CNS Lymphoma | CNS Brain CancerUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; Weill Medical College of Cornell UniversityCompletedGastric Cancer | Esophageal CancerUnited States